• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»degrader-antibody conjugates

Can Orum Therapeutics crack one of AML’s hardest problems with ORM-1153? AACR 2026 data spark fresh attention

By Pallavi Madhiraju on April 18, 2026   Pharma & Biotech  

Can Orum Therapeutics crack one of AML’s hardest problems with ORM-1153? AACR 2026 data spark fresh attention

Orum Therapeutics unveiled AACR 2026 data for ORM-1153 in AML. Read why the CD123 degrader strategy could matter for efficacy and tolerability.

Recent Posts

  • Why Gilead’s Arcellx acquisition approval could reshape the multiple myeloma CAR-T race
  • Can PreludeDx and Quanterix turn AidaBREAST into a new standard for radiation therapy decisions
  • Why everyone watching neurology at AAN 2026 may end up talking about Acadia Pharmaceuticals
  • Salubris Biotherapeutics expands JK06 data at AACR 2026 with encouraging responses in difficult solid tumors
  • Can OncoNano Medicine’s ON-BOARD platform solve antigen limits in solid tumor drug delivery?
  • Can Orum Therapeutics crack one of AML’s hardest problems with ORM-1153? AACR 2026 data spark fresh attention
  • How NEU-002 could reshape Onchilles Pharma’s systemic solid tumor strategy after AACR 2026
  • Is CD39 finally ready for a breakout moment in lung cancer? Innate Pharma tests the thesis
  • Can bispecific ADCs give NEOK Bio a more credible route into solid tumor drug development?
  • AACR 2026: SingleCell Biotechnology targets oncology’s blind spot with functional single-cell profiling
  • Can Zai Lab’s ZL-1503 turn dual-pathway itch control into a real atopic dermatitis advantage?
  • IntoDNA unveils sSTRIDE-NER and sSTRIDE-PARP1 at AACR 2026, can functional DNA repair assays reshape precision oncology?
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes